Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moffitt has contributed to major advances in oncology such as leading nationwide clinical trials that resulted in initial FDA approvals for CAR T-cell therapy. It operates five multidisciplinary research programs spanning basic science through translational and clinical research. The center’s Total Cancer Care® initiative aims to deliver personalized therapy based on genetic profiling of tumors. It remains the only NCI Comprehensive Cancer Center based in Florida and serves as a leader in both scientific discovery and compassionate patient care
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moffitt Cancer Center.